Continuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 drugs like Ozempic.

Moderate-risk patients with diabetes treated with a sulfonylurea appear to be at a higher risk of major adverse cardiovascular events than those who receive a dipeptidyl peptidase-4 (DPP-4) inhibitor, ...

Background: A 12-week-old female presented with neonatal diabetes. Insulin therapy alleviated the diabetes, but the patient showed marked motor and mental developmental delay. The patient underwent ...

Glyburide 1.5mg, 3mg, 6mg; scored tabs. Glyburide appears to lower the blood glucose acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in ...

Honolulu, Hawaii — The dramatic results of a small study testing an intravenous formulation of a common diabetes drug are causing something of a stir in the stroke community. Although the GAMES ...

CHICAGO, July 10 (Reuters) - A new class of diabetes drugs touted by drugmakers was moderately effective in controlling blood sugar levels without adding extra weight, but more long-term data are ...

Study of 333,000 U.S. veterans finds stopping GLP-1 drugs, even temporarily, quickly erodes cardiovascular benefits and raises heart attack and stroke risk.